Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Toxicological Sciences

• Publication date

  2009-06-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/toxsci/kfp055PMID 19293372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant transthyretin purification and competitive binding with organohalogen compounds in two gull species (Larus argentatus and Larus hyperboreus).

  2009cited by this paper
• Halogenated contaminants in farmed salmon, trout, tilapia, pangasius, and shrimp.

  2009cited by this paper
• Perfluorinated compounds--exposure assessment for the general population in Western countries.

  2009cited by this paper
• Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).

  2008cited by this paper
• Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47).

  2008cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Disruption of thyroid hormone binding to sea bream recombinant transthyretin by ioxinyl and polybrominated diphenyl ethers.

  2007cited by this paper
• Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals.

  2007cited by this paper
• Selected Titles

  2006cited by this paper
• Biological monitoring of polyfluoroalkyl substances: A review.

  2006cited by this paper
• Perfluorinated chemicals in relation to other persistent organic pollutants in human blood.

  2006cited by this paper
• Predicting the Partitioning Behavior of Various Highly Fluorinated Compounds

  2006cited by this paper
• Predicting the partitioning behavior of various highly fluorinated compounds.

  2006cited by this paper
• Perfluorinated alkylated substances (PFAS) in the Nordic environment Perfluorinated alkylated substances (PFAS) in the Nordic environment

  2004cited by this paper
• Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy

  2004cited by this paper
• The developmental toxicity of perfluoroalkyl acids and their derivatives.

  2004cited by this paper
• The Polar Hydrophobicity of Fluorinated Compounds

  2004cited by this paper
• Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.

  2004cited by this paper
• Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.

  2003cited by this paper
• Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.

  2003cited by this paper
• Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats.

  2003cited by this paper
• Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss)

  2003cited by this paper
• Binding of perfluorinated fatty acids to serum proteins

  2003cited by this paper
• Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

  2003cited by this paper
• Interactions of flurochemicals with rat liver fatty acid-binding protein

  2002cited by this paper
• Interactions of fluorochemicals with rat liver fatty acid-binding protein.

  2002cited by this paper
• Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo.

  2002cited by this paper
• Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys.

  2002cited by this paper
• Mechanisms of Molecular Recognition: Crystal Structure Analysis of Human and Rat Transthyretin Inhibitor Complexes

  2002cited by this paper
• Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.

  2000cited by this paper
• Analysis of Surfactants

  2000cited by this paper
• Structure of human transthyretin complexed with bromophenols: a new mode of binding.

  2000cited by this paper
• Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.

  1998cited by this paper
• Discovering transthyretin amyloid fibril inhibitors by limited screening.

  1998cited by this paper
• The cerebral expression of plasma protein genes in different species.

  1995cited by this paper
• Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin.

  1993cited by this paper
• Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats.

  1992cited by this paper
• A User's Guide to Principal Components.

  1991cited by this paper
• Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin.

  1990cited by this paper
• Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin.

  1990cited by this paper
• Cerebrospinal fluid transthyretin in the neonate and blood–cerebrospinal fluid barrier permeability

  1989cited by this paper
• Photoaffinity labeling of human thyroxine-binding prealbumin with thyroxine and N-(ethyl-2-diazomalonyl)thyroxine.

  1982cited by this paper
• Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models

  1978cited by this paper
• Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

  1977cited by this paper
• Polymorphism of Rhesus monkey serum prealbumin. Purification and partial structure.

  1973cited by this paper

• Longitudinal PFAS exposure and thyroid function trajectories in Taiwanese youth: a 10-year prospective cohort study.

  2026cites this paper
• Biological pathways of per- and polyfluoroalkyl substances (PFAS): A critical review of cellular and molecular toxicity mechanisms.

  2026cites this paper
• Quantitative acetylomic analysis reveals a key role of acetylation site 1168K in carbamoyl-phosphate synthase 1 (CPS1) following exposure to PFOA and PFO4DA in mouse liver.

  2026cites this paper
• PFOS exposure at environmentally relevant concentrations promote papillary thyroid carcinoma progression through PI3K/AKT/mTOR-mediated epithelial-mesenchymal transition.

  2026cites this paper
• Apical effects of simulated maternal exposure of salmonid fishes to novel and typical per- and poly-fluoroalkyl substances.

  2025cites this paper
• Advances in kidney disease: pathogenesis and therapeutic targets

  2025cites this paper
• Per- and polyfluoroalkyl substances (PFAS), thyroid hormones, sexual hormones and pubertal development in adolescents residing in the neighborhood of a 3M factory

  2025cites this paper
• Identifying possible neurodevelopmental effects of per- and polyfluoroalkyl substances (PFAS) through an adverse outcome pathway (AOP) network for human developmental neurotoxicology.

  2025cites this paper
• Consensus Modeling Strategies for Predicting Transthyretin Binding Affinity from Tox24 Challenge Data

  2025cites this paper
• Effect-based and (non-)target chemical analyses reveal concerning levels of emerging contaminants in urban streams in Sub-Saharan Africa.

  2025cites this paper
• Association and binding interaction between per- and polyfluoroalkyl substances and maternal thyroid hormones: A case study based on a prospective birth cohort in Wuxi, China.

  2025cites this paper
• Serum per- and polyfluoroalkyl substances in relation to circulating thyroxine levels and thyroid cancer risk: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial cohort.

  2025cites this paper
• Biomarker responses in wild brown trout from a headwater stream and their causal link to water pollution assessed through chemical analysis and in vitro reporter gene bioassays.

  2025cites this paper
• Effects of thyroid disruption on neural cells stem fate in the mouse brain.

  2025cites this paper
• Assessing PFAS mixture exposure and thyroid function in U.S. adolescents: insights from NHANES 2011–2012

  2025cites this paper
• Endocrine disruption potential of dust in children's indoor environments: Associations with multiple chemicals from various compound classes across exposure matrices used for health risk assessment.

  2025cites this paper
• Per- and polyfluoroalkyl substances in environment and potential health impacts: Sources, remediation treatment and management, policy guidelines, destructive technologies, and techno-economic analysis.

  2025cites this paper
• High-throughput screening of protein interactions with per- and polyfluoroalkyl substances (PFAS) used in photolithography.

  2025cites this paper
• LC-HRMS analysis of ultrashort- and short-chain PFAS on porous graphitic carbon column and study of accumulation in plants

  2025cites this paper
• New QSAR Models to Predict Human Transthyretin Disruption by Per- and Polyfluoroalkyl Substances (PFAS): Development and Application

  2025cites this paper
• Molecular docking-QSAR-Kronecker-regularized least squares-based multiple machine learning for assessment and prediction of PFAS-protein binding interactions.

  2025cites this paper
• In vitro and in vivo thyroid hormone system disruption by perfluorooctane sulfonate (PFOS) and tetrabromobisphenol A (TBBPA).

  2025cites this paper
• Exposure of free-ranging white-tailed deer (Odocoileus virginianus) to per- and polyfluoroalkyl substances (PFAS) at PFAS-impacted sites in Minnesota.

  2025cites this paper
• Sustainable remediation strategies for emerging PFAS contaminants in water

  2025cites this paper
• Identification of new PFAS for severe interference with thyroid hormone transport: A combined in vitro/silico approach.

  2025cites this paper
• Prenatal per- and polyfluoroalkyl substances (PFAS) exposure and maternal thyroid homeostasis: Nonlinear, compound-specific, and mixture effects

  2025cites this paper
• A Review of Quantitative Structure–Activity Relationship (QSAR) Models to Predict Thyroid Hormone System Disruption by Chemical Substances

  2025cites this paper
• Using molecular dynamics simulation to enhance conservation analysis for cross species extrapolation of the PFOA-Transthyretin interaction.

  2025cites this paper
• Association between per- and polyfluoroalkyl substance exposures and thyroid homeostasis parameters.

  2024cites this paper
• Pyrethroid exposure biomarker 3-phenoxybenzoic acid (3-PBA) binds to transthyretin and is positively associated with free T3 in pregnant women.

  2024cites this paper
• The paradox of spring: Thyroid and glucocorticoid responses to cold temperatures and food availability in free living Carneddau ponies.

  2024cites this paper
• Dose-Dependent Effects of PFOS on Thyroid Hormone-Driven Neurodevelopment and Metamorphic-like change in Xenopus laevis larvae

  2024cites this paper
• Per- and Polyfluoroalkyl Substances (PFAS) Affect Female Reproductive Health: Epidemiological Evidence and Underlying Mechanisms

  2024cites this paper
• Identification of polar bioactive substances in the Upper Rhine using effect-directed analysis.

  2024cites this paper
• Triiodothyronine (T3), but not resting metabolic rate correlates positively with per- and polyfluoroalkyl substances (PFAS) in Arctic terns.

  2024cites this paper
• Screening the ToxCast Chemical Libraries for Binding to Transthyretin.

  2024cites this paper
• Associations of per- and polyfluoroalkyl substances and alternatives with subclinical hypothyroidism in children: A cross-sectional study in China.

  2024cites this paper
• Association between PFAS exposure and thyroid health: A systematic review and meta-analysis for adolescents, pregnant women, adults and toxicological evidence.

  2024cites this paper
• Identification of new endocrine disruptive transthyretin ligands in polluted waters using pull-down assay coupled to non-target mass spectrometry.

  2024cites this paper
• Segmentation of Renal Thyroid Follicle Colloid in Common Carp: Insights into Perfluorooctanoic Acid-Induced Morphometric Alterations

  2024cites this paper
• Two novel in vitro assays to screen chemicals for their capacity to inhibit thyroid hormone transmembrane transporter proteins OATP1C1 and OAT4

  2024cites this paper
• Species Difference? Bovine, Trout, and Human Plasma Protein Binding of Per- and Polyfluoroalkyl Substances

  2024cites this paper
• Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.

  2024cites this paper
• Associations between per- and polyfluoroalkyl substances exposure and thyroid hormone levels in the elderly.

  2024cites this paper
• Perfluorooctanesulfonic acid (PFOS) disrupts cadherin-16 in the developing rat thyroid gland

  2024cites this paper
• Identification of Hydrocarbon Sulfonates as Previously Overlooked Transthyretin Ligands in the Environment.

  2024cites this paper
• Associations between serum per- and polyfluoroalkyl substances and thyroid hormones in Chinese adults: A nationally representative cross-sectional study.

  2024cites this paper
• Overview of Per- and Polyfluoroalkyl Substances (PFAS), Their Applications, Sources, and Potential Impacts on Human Health

  2024cites this paper
• Perfluoroalkylated substances – an endocrine disruptor with reprotoxic effects

  2024cites this paper
• Polychlorinated alkanes in paired blood serum and breast milk in a Swedish cohort study: Matrix dependent partitioning differences compared to legacy POPs.

  2024cites this paper
• Characterization of thyroid hormone transport in a human choroid plexus papilloma cell line (HIBCPP) as an in vitro blood-cerebrospinal fluid barrier model.

  2024cites this paper
• In silico models for the screening of human transthyretin disruptors.

  2024cites this paper
• Thyroid endocrine disruption effects of OBS in adult zebrafish and offspring after parental exposure at early life stage.

  2024cites this paper
• The pollutant perfluorohexane sulfonate (PFHxS) reduces serum thyroxine but does not alter thyroid action in the postnatal rat brain

  2024cites this paper
• Emerging and legacy contaminants in common minke whale from the Barents sea.

  2023cites this paper
• First Discovery of Iodinated Polyfluoroalkyl Acids by Nontarget Mass-Spectrometric Analysis and Iodine-Specific Screening Algorithm.

  2023cites this paper
• Exposure to Persistent Organic Pollutants in Danish pregnant women: hormone levels and fetal growth indices.

  2023cites this paper
• Novel PFOS alternative OBS inhibits body growth of developing zebrafish by triggering thyroid function disorder and osteoclast differentiation.

  2023cites this paper
• 6:2 Chlorinated Polyfluoroalkyl Ether Sulfonates Exert Stronger Thyroid Homeostasis Disruptive Effects in Newborns than Perfluorooctanesulfonate: Evidence Based on Bayesian Benchmark Dose Values from a Population Study.

  2023cites this paper
• Exposure to perfluoroalkyl substances (PFAS) and association with thyroid hormones in adolescent males.

  2023cites this paper
• Association of exposure to perfluoroalkyl substances (PFAS) and phthalates with thyroid hormones in adolescents from HBM4EU aligned studies.

  2023cites this paper
• Perfluorooctanoic acid (PFOA) exposure in relation to the kidneys: A review of current available literature

  2023cites this paper
• The interference between effects of PFAS exposure on thyroid hormone disorders and cholesterol levels: an NHANES analysis

  2023cites this paper
• A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per‐ and polyfluoroalkyl substances and relevance to human health

  2023influential citation
• Linking Transthyretin-Binding Chemicals and Free Thyroid Hormones: In Vitro to In Vivo Extrapolation Based on a Competitive Binding Model.

  2023cites this paper
• Sex-specific effect of perfluoroalkyl substances exposure on liver and thyroid function biomarkers: A mixture approach.

  2023cites this paper
• Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheath

  2023cites this paper
• Effect of dietary antioxidants on excretion of perfluorooctanoic acid (PFOA) via regulating uptake transporters expression and intestinal permeability in mice.

  2023cites this paper
• Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes.

  2023cites this paper
• Mediating effect of endocrine hormones on association between per- and polyfluoroalkyl substances exposure and birth size: Findings from sheyang mini birth cohort study.

  2023cites this paper
• High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.

  2023cites this paper
• Screening for endocrine disrupting chemicals inhibiting monocarboxylate 8 (MCT8) transporter facilitated thyroid hormone transport using a modified nonradioactive assay.

  2023cites this paper
• PFAS: forever chemicals—persistent, bioaccumulative and mobile. Reviewing the status and the need for their phase out and remediation of contaminated sites

  2023cites this paper
• In vitro screening of per- and polyfluorinated substances (PFAS) for interference with seven thyroid hormone system targets across nine assays.

  2023cites this paper
• Elucidating Key Characteristics of PFAS Binding to Human Peroxisome Proliferator-Activated Receptor Alpha: An Explainable Machine Learning Approach.

  2023cites this paper
• Electrochemical Oxidation for Treatment of PFAS in Contaminated Water and Fractionated Foam—A Pilot-Scale Study

  2023cites this paper
• Towards higher scientific validity and regulatory acceptance of predictive models for PFAS

  2023cites this paper
• Associations of prenatal PFAS exposure and early childhood neurodevelopment: Evidence from the Shanghai Maternal-Child Pairs Cohort.

  2023cites this paper
• Structure-Related Thyroid Disrupting Effect of Perfluorooctanesulfonate-like Substances in Zebrafish Larvae.

  2023cites this paper
• Effect‐Directed Analysis Based on Transthyretin Binding Activity of Per‐ and Polyfluoroalkyl Substances in a Contaminated Sediment Extract

  2023influential citation
• Assessment of five typical environmental endocrine disruptors and thyroid cancer risk: a meta-analysis

  2023cites this paper
• The contribution of PFAS to thyroid hormone-displacing activity in Dutch waters: A comparison between two in vitro bioassays with chemical analysis.

  2023cites this paper
• Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study.

  2023cites this paper
• Study on Quantification and Toxicity Estimation of Perfluoroalkyl Substances in Vietnamese Fish and Food Packaging Materials

  2023cites this paper
• Studying mixture effects on uptake and tissue distribution of PFAS in zebrafish (Danio rerio) using physiologically based kinetic (PBK) modelling.

  2023cites this paper
• A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics

  2023cites this paper
• Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis

  2023influential citation
• Probing the Interactions of Perfluorocarboxylic Acids of Various Chain Lengths with Human Serum Albumin: Calorimetric and Spectroscopic Investigations.

  2023cites this paper
• In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS)

  2022cites this paper
• Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Childhood Autism-related Outcomes

  2022cites this paper
• Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny—part III: how is substance-mediated thyroid hormone imbalance in pregnant/lactating rats or their progeny related to neurodevelopmental effects?

  2022cites this paper
• Associations of per- and polyfluoroalkyl substances and their alternatives with bone mineral density levels and osteoporosis prevalence: A community-based population study in Guangzhou, Southern China.

  2022cites this paper
• Binding of common organic UV-filters to the thyroid hormone transport protein transthyretin using in vitro and in silico studies: Potential implications in health.

  2022cites this paper
• Reduced Birth Weight and Exposure to Per- and Polyfluoroalkyl Substances: A Review of Possible Underlying Mechanisms Using the AOP-HelpFinder

  2022cites this paper
• The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment.

  2022cites this paper
• Comment on "Associations between Novel and Legacy Per- and Polyfluoroalkyl Substances in Human Serum and Thyroid Cancer: A Case and Healthy Population in Shandong Province, East China".

  2022cites this paper
• Association of per- and polyfluoroalkyl substances with thyroid homeostasis during pregnancy in the SELMA study.

  2022cites this paper
• Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System

  2022cites this paper
• Estimated daily intake of per- and polyfluoroalkyl substances related to different particle size fractions of house dust.

  2022cites this paper
• Lack of interaction of the fluorosurfactant C6O4 with human renal transporters: in vitro/in silico analysis.

  2022cites this paper